Why is Brooks Lab. falling/rising?

As of 19-Sep, Brooks Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 147.95, which reflects a decrease of 1.05 or 0.7%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 6.95% during this period. Today's performance indicates that it underperformed its sector by 0.97%. Despite a high of Rs 152.9 earlier in the day, the stock's delivery volume has significantly decreased by 52.05% compared to the five-day average, suggesting a drop in investor participation. While the company has reported strong growth in net profit and positive results over the last three quarters, its long-term fundamentals are weak, with an average return on equity of 0% and a concerning EBIT to interest ratio of -3.82.
In the broader market context, Brooks Laboratories Ltd's short-term performance has been notably poor, with a one-week return of -6.33%, contrasting sharply with the Sensex, which has gained 0.88% over the same period. This underperformance is further highlighted by the stock's year-to-date decline of 20.01%, while the Sensex has risen by 5.74%. The stock's valuation appears expensive relative to its peers, with a price-to-book ratio of 4.5, despite trading at a discount compared to historical valuations. Overall, the combination of weak investor participation, declining short-term returns, and poor long-term growth prospects contributes to the stock's downward movement.